Pediatr. praxi. 2009;10(2):114-117

Long-term experiences with home oxygenotherapy in premature infants with bronchopulmonary dysplásia

MUDr. Jiří Dort, MUDr. Eva Dortová
Neonatologické oddělení, FN a LF UK, Plzeň

Bronchopulmonary dysplasia occures in a significant proportion of premature infants in the Czech Republic as well as in other developed

countries. The oxygenotherapy is part of treament. Authors describe their own experiences with the long-term home oxygenotherapy

administration in a group of 32 infants (mean gestational age 26,3 wks, mean birth weight 784 G). The average duration of home oxygenotherapy

was 168 days. The main advantage of home oxygenotherapy is a shorter hospital stay resulting in a better psychomotor

development support, family – child bonding, nosocomial infections elimination and lower health care costs. The mobile unit with fluid

oxygen enables a good infant’s mobility. No complications of the oxygenotherapy at home conditions appeared. The authors discuss

other treatment possibilities in infants with bronchopulmonary dysplasia.

Keywords: preterm infants, bronchopulmonary dysplasia, home oxygenotherapy.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dort J, Dortová E. Long-term experiences with home oxygenotherapy in premature infants with bronchopulmonary dysplásia. Pediatr. praxi. 2009;10(2):114-117.
Download citation

References

  1. Bancalari E, Wilson-Costello D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev. 2005; 81(2): 171-179. Go to original source... Go to PubMed...
  2. Baraldi E, Carra S, Vencato F, Filippone M, Trevisanuto D, Milanesi O, Pinello M, Zanardo V, Zacchello F. Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study. Eur J Pediatr. 1997; 156(11): 878-882. Go to original source... Go to PubMed...
  3. Beca JP, Torres J, Sfeir J, Rodriguez G, Pena M, Vila A. Home oxygen therapy in children with bronchopulmonary dysplasia. Rev Chil Pediatr. 1990; 61(5): 267-270. Go to original source... Go to PubMed...
  4. Bertrand P, Alvarez C, Fabres J, Simonetti M, Sanchez I. (Home oxygen therapy in children with chronic respiratory failure) Rev Med Chil. 1998; 126(3): 284-292. Go to PubMed...
  5. Dlouhodobá domácí oxygenoterapie (DDOT) Čs. Pediat., 1994; 49(1): 44-45. Go to original source...
  6. Dort J, Dortová E, Mocková A. Domácí oxygenoterapie pro děti s chronickou plicní chorobou. Čes. slov. Pediat., 2004; 59(1): 3-7.
  7. Ellsbury DL, Acarregui MJ, McGuinness GA, Eastman DL, Klein JM. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia. J Perinatol. 2004; 24(1): 36-40. Go to original source... Go to PubMed...
  8. Fauroux B, Sardet A, Foret D. Home treatment for chronic respiratory failure in children: a prospective study. Eur Respir J. 1995; 8(12): 2062-2066. Go to original source... Go to PubMed...
  9. Gracey K, Talbot D, Lankford R, Dodge P. The changing face of bronchopulmonary dysplasia: Part 2. Discharging an infant home on oxygen. Adv Neonatal Care. 2003; 3(2): 88-98. Go to original source... Go to PubMed...
  10. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729. Go to original source... Go to PubMed...
  11. Kotecha S, Allen J. Oxygen therapy for infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2002; 87: F11-14. Go to original source... Go to PubMed...
  12. Norzila MZ, Azizi BH, Norrashidah AW, Yeoh NM, Deng CT. Home oxygen therapy for children with chronic lung diseases. Med J Malaysia. 2001; 56(2): 151-157. Go to PubMed...
  13. Saletti A, Stick S, Doherty D, Simmer K. Home oxygen therapy after preterm birth in Western Australia. J Paediatr Child Health. 2004; 40(9-10): 519-523. Go to original source... Go to PubMed...
  14. Sauve RS, McMillan DD, Mitchell I, Creighton D, Hindle NW, Young L. Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment. Clin Pediatr (Phila) 1989; 28(3): 113-118. Go to original source... Go to PubMed...
  15. Thomas W, Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Hum Dev. 2005; 81(2): 155-163. Go to original source... Go to PubMed...
  16. Zanardo V, Freato F. Home oxygen therapy in infants with bronchopulmonary dysplasia: assessment of parental anxiety. Early Hum Dev. 2001; 65(1): 39-46. Go to original source... Go to PubMed...
  17. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thébaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 2005; 172: 750-756. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.